Transdermal Skin Patches Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
Global Transdermal Skin Patches Market is expected to reach US$ 9.6 Billion in 2027. Transdermal skin patches are a non-invasive and simple means of delivering steady and consistent therapeutic doses into the bloodstream over a set period. Backings, medicines, membranes, adhesives, liners, chemical enhancers and permeates, physical assistance, and low electrical current techniques such as iontophoresis are among them. Depending on the skin's properties and the patch's design, they provide a uniform diffusion rate. They are currently widely utilized worldwide as cosmetic, topical, and transdermal delivery systems.
The primary factors driving the transdermal skin patches market expansion are the rising benefits of transdermal medicine over oral and swallowing drugs (medications for gastrointestinal toxicity) that cause nausea and vomiting. They are less inconvenient than intravenous or parenteral therapies since they are non-invasive. The key benefit is that the patch allows for regulated drug release to the patient, usually accomplished by a perforated membrane covering the drug reservoir or by body warmth dissolving small layers of medication in the adhesive.
COVID-19 Outbreak Boosted the Transdermal Patch Market Size:
The COVID-19 outbreak has likely had a beneficial effect on the market for transdermal skin patches. These patches make it possible to administer medications to a specific skin microenvironment safely, repeatable, and regulated manner. As a result, researchers working on a potential COVID-19 vaccination were looking into using a fingertip-sized skin patch to deliver the vaccine. According to Renub Research, Global Transdermal Skin Patches Market Is Foreseen to Register a CAGR of 3.52% during 2021-2027.
Worldwide Transdermal Skin Patches Market Size was US$ 7.8 Billion in 2021.
The transdermal skin patches market is split by Type and Application in our analysis. Furthermore, the growth of these segments assists in the study of the industries' meagre growth. It provides a vital market overview and industry insights to aid in strategic decision-making to identify core market applications.
By Types, the Transdermal Skin Patches Market is divided into three types: Single Layer Drug Adhesive, Multi-Layer Drug Adhesive, and Matrix.
By Application, the Transdermal Skin Patches Market is divided into four categories: Pain Management, Hormonal Application, Central Nervous System Disorder, and Cardiovascular Diseases.
Transdermal Skin Patches Market Regional Level Analysis:
North America, Asia Pacific, Europe, and Rest of World are the critical regions in our transdermal skin patches market study. According to our research, North America dominates the transdermal patches market due to the increasing presence of key players and established healthcare infrastructure, increasing beneficial government initiatives, increasing the number of research partnerships, increasing the adoption of various strategies such as product innovation, and increasing product launches and approval in this region.
Competitive Landscape:
The market for transdermal skin patches is competitive. Leading companies focus on product innovations, product launches and approvals, R&D investment for advancements in transdermal patches, and mergers and acquisitions as developmental strategies to stay competitive in the industry. Teva Pharmaceutical Industries Ltd, Novartis AG, Mylan NV (Viatris), Luye Pharma Group, Bayer HealthCare Pharmaceuticals, Allergan, 3M Health Care Business Group, and Henan Lingrui Pharmaceutical Ltd are some of the key players in the market.
Renub Research latest report “Transdermal Skin Patches Market, Global Forecast By Type (Single Layer Drug Adhesive, Multi-Layer Drug Adhesive, and Matrix), Application (Pain Management, Hormonal Application, Central Nervous System Disorder, and Cardiovascular Diseases), Region (North America, Asia Pacific, Europe, and ROW), Companies (Teva Pharmaceutical Industries Ltd, Novartis AG, Mylan NV (Viatris), Luye Pharma Group, Bayer HealthCare Pharmaceuticals, Allergan, 3M Health Care Business Group, and Henan Lingrui Pharmaceutical Ltd)” provides a detailed analysis of Transdermal Skin Patches Industry.
Type - Market has been covered from 4 viewpoints:
1. Single Layer Drug Adhesive
2. Multi-Layer Drug Adhesive
3. Matrix
4. Others
Application - Market has been covered from 5 viewpoints:
1. Pain Management
2. Hormonal Application
3. Central Nervous System Disorder
4. Cardiovascular Diseases
5. Others
Regions - Market has been covered from 4 viewpoints:
1. North America
2. Asia Pacific
3. Europe
4. Rest of World
Company Insights:
• Company Profile
• Recent Developments
• Revenue
Companies Covered:
1. Teva Pharmaceutical Industries Ltd
2. Novartis AG
3. Mylan NV (Viatris)
4. Luye Pharma Group
5. Bayer HealthCare Pharmaceuticals
6. Allergan
7. 3M Health Care Business Group
8. Henan lingrui pharmaceutical ltd
- 1. Introduction
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
- 5. Global Transdermal Skin Patch Market
- 6. Market Share
- 6.1 By Type
- 6.2 By Application
- 6.3 By Regions
- 7. Type – Global Transdermal Skin Patches Market
- 7.1 Single Layer Drug Adhesive
- 7.2 Multi-Layer Drug Adhesive
- 7.3 Matrix
- 7.4 Others
- 8. Application – Global Transdermal Skin Patches Market
- 8.1 Pain Management
- 8.2 Hormonal Application
- 8.3 Central Nervous System Disorder
- 8.4 Cardiovascular Diseases
- 8.5 Others
- 9. Regions – Global Transdermal Skin Patches Market
- 9.1 North America
- 9.2 Asia Pacific
- 9.3 Europe
- 9.4 Rest of World
- 10. Porters Five Forces
- 10.1 Bargaining Power of Buyers
- 10.2 Bargaining Power of Suppliers
- 10.3 Degree of Competition
- 10.4 Threat of New Entrants
- 10.5 Threat of Substitutes
- 11. Company Analysis
- 11.1 Teva Pharmaceutical Industries Ltd
- 11.1.1 Company Profile
- 11.1.2 Recent Developments
- 11.1.3 Revenue
- 11.2 Novartis AG
- 11.2.1 Company Profile
- 11.2.2 Recent Developments
- 11.2.3 Revenue
- 11.3 Mylan NV (Viatris)
- 11.3.1 Company Profile
- 11.3.2 Recent Developments
- 11.3.3 Revenue
- 11.4 Luye Pharma Group
- 11.4.1 Company Profile
- 11.4.2 Recent Developments
- 11.4.3 Revenue
- 11.5 Bayer HealthCare Pharmaceuticals
- 11.5.1 Company Profile
- 11.5.2 Recent Developments
- 11.5.3 Revenue
- 11.6 Allergan
- 11.6.1 Company Profile
- 11.6.2 Recent Developments
- 11.6.3 Revenue
- 11.7 3M Health Care Business Group
- 11.7.1 Company Profile
- 11.7.2 Recent Developments
- 11.7.3 Revenue
- 11.8 Henan lingrui pharmaceutical ltd
- 11.8.1 Company Profile
- 11.8.2 Recent Developments
- 11.8.3 Revenue
- List of Figures:
- Figure-01: Global – Transdermal Skin Patch Market (Billion US$), 2017 – 2021
- Figure-02: Global – Forecast for Transdermal Skin Patch Market (Billion US$), 2022 – 2027
- Figure-03: Type – Single Layer Drug Adhesive Market (Million US$), 2017 – 2021
- Figure-04: Type – Forecast for Single Layer Drug Adhesive Market (Million US$), 2022 – 2027
- Figure-05: Type – Multi-Layer Drug Adhesive Market (Million US$), 2017 – 2021
- Figure-06: Type – Forecast for Multi-Layer Drug Adhesive Market (Million US$), 2022 – 2027
- Figure-07: Type – Matrix Market (Million US$), 2017 – 2021
- Figure-08: Type – Forecast for Matrix Market (Million US$), 2022 – 2027
- Figure-09: Type – Others Market (Million US$), 2017 – 2021
- Figure-10: Type – Forecast for Others Market (Million US$), 2022 – 2027
- Figure-11: Application – Pain Management Market (Million US$), 2017 – 2021
- Figure-12: Application – Forecast for Pain Management Market (Million US$), 2022 – 2027
- Figure-13: Application – Hormonal Application Market (Million US$), 2017 – 2021
- Figure-14: Application – Forecast for Hormonal Application Market (Million US$), 2022 – 2027
- Figure-15: Application – Central Nervous System Disorder Market (Million US$), 2017 – 2021
- Figure-16: Application – Forecast for Central Nervous System Disorder Market (Million US$), 2022 – 2027
- Figure-17: Application – Cardiovascular Diseases Market (Million US$), 2017 – 2021
- Figure-18: Application – Forecast for Cardiovascular Diseases Market (Million US$), 2022 – 2027
- Figure-19: Application – Others Market (Million US$), 2017 – 2021
- Figure-20: Application – Forecast for Others Market (Million US$), 2022 – 2027
- Figure-21: North America – Transdermal Skin Patch Market (Million US$), 2017 – 2021
- Figure-22: North America – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
- Figure-23: Asia Pacific – Transdermal Skin Patch Market (Million US$), 2017 – 2021
- Figure-24: Asia Pacific – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
- Figure-25: Europe – Transdermal Skin Patch Market (Million US$), 2017 – 2021
- Figure-26: Europe – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
- Figure-27: Rest of World – Transdermal Skin Patch Market (Million US$), 2017 – 2021
- Figure-28: Rest of World – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
- Figure-29: Teva Pharmaceutical Industries Ltd – Global Revenue (Million US$), 2017 – 2021
- Figure-30: Teva Pharmaceutical Industries Ltd – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-31: Novartis AG – Global Revenue (Million US$), 2017 – 2021
- Figure-32: Novartis AG – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-33: Mylan NV (Viatris) – Global Revenue (Million US$), 2017 – 2021
- Figure-34: Mylan NV (Viatris) – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-35: Luye Pharma Group – Global Revenue (Million US$), 2017 – 2021
- Figure-36: Luye Pharma Group – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-37: Bayer HealthCare Pharmaceuticals – Global Revenue (Million US$), 2017 – 2021
- Figure-38: Bayer HealthCare Pharmaceuticals – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-39: Allergan – Global Revenue (Million US$), 2017 – 2021
- Figure-40: Allergan – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-41: 3M Health Care Business Group – Global Revenue (Million US$), 2017 – 2021
- Figure-42: 3M Health Care Business Group – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-43: Henan lingrui pharmaceutical ltd – Global Revenue (Million US$), 2017 – 2021
- Figure-44: Henan lingrui pharmaceutical ltd – Forecast for Global Revenue (Million US$), 2022 – 2027
- List of Tables:
- Table-01: Global – Transdermal Skin Patch Market Share by Type (Percent), 2017 – 2021
- Table-02: Global – Forecast for Transdermal Skin Patch Market Share by Type (Percent), 2022 – 2027
- Table-03: Global – Transdermal Skin Patch Market Share by Application (Percent), 2017 – 2021
- Table-04: Global – Forecast for Transdermal Skin Patch Market Share by Application (Percent), 2022 – 2027
- Table-05: Global – Transdermal Skin Patch Market Share by Region (Percent), 2017 – 2021
- Table-06: Global – Forecast for Transdermal Skin Patch Market Share by Region (Percent), 2022 – 2027
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook